SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-029384
Filing Date
2024-07-29
Accepted
2024-07-29 09:15:16
Documents
34
Period of Report
2024-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 59256
2 ex4-1.htm EX-4.1 109329
3 ex10-2.htm EX-10.2 9632
4 ex10-1.htm EX-10.1 95319
5 ex10-3.htm EX-10.3 27057
6 ex99-1.htm EX-99.1 15379
7 ex4-1_001.jpg GRAPHIC 5097
8 ex10-1_001.jpg GRAPHIC 5106
9 ex10-2_001.jpg GRAPHIC 400480
10 ex10-2_002.jpg GRAPHIC 492269
11 ex10-2_003.jpg GRAPHIC 470804
12 ex10-2_004.jpg GRAPHIC 123756
13 ex10-2_005.jpg GRAPHIC 95395
14 ex10-2_006.jpg GRAPHIC 156452
15 ex10-2_007.jpg GRAPHIC 27833
16 ex10-2_008.jpg GRAPHIC 170640
17 ex10-2_009.jpg GRAPHIC 633206
18 ex10-2_010.jpg GRAPHIC 640897
19 ex10-2_011.jpg GRAPHIC 460563
20 ex10-2_012.jpg GRAPHIC 44678
21 ex99-1_001.jpg GRAPHIC 2914
  Complete submission text file 0001493152-24-029384.txt   5726177

Data Files

Seq Description Document Type Size
22 XBRL SCHEMA FILE cldi-20240726.xsd EX-101.SCH 3813
23 XBRL DEFINITION FILE cldi-20240726_def.xml EX-101.DEF 26683
24 XBRL LABEL FILE cldi-20240726_lab.xml EX-101.LAB 36817
25 XBRL PRESENTATION FILE cldi-20240726_pre.xml EX-101.PRE 25307
36 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6006
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40789 | Film No.: 241149207
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)